Although our RNA-Seq analysis identified NEPC as a cancer subtype in which NKX2–1 mutations are associated with increased PSPH mRNA expression (Fig. 1f), we did not further investigate this cancer subtype, due to the limited availability of prostate cancer models with neuroendocrine origin. This evidence concerns the gene NKX2-1 and prostate carcinoma.